Iterum Therapeutics plc Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Iterum Therapeutics plc quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Iterum Therapeutics plc Operating Lease, Payments for the quarter ending June 30, 2024 was $100K, a 1.96% decline year-over-year.
  • Iterum Therapeutics plc Operating Lease, Payments for the twelve months ending June 30, 2024 was $350K, a 25.5% decline year-over-year.
  • Iterum Therapeutics plc annual Operating Lease, Payments for 2023 was $354K, a 50.1% decline from 2022.
  • Iterum Therapeutics plc annual Operating Lease, Payments for 2022 was $709K, a 24.9% decline from 2021.
  • Iterum Therapeutics plc annual Operating Lease, Payments for 2021 was $944K, a 15.4% decline from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $354K -$355K -50.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $709K -$235K -24.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $944K -$172K -15.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $1.12M +$290K +35.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 $826K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.